High prevalence of BRCA1 stop mutation c.4183C>T in the Tyrolean population: implications for genetic testing

about

Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple-negative breast cancer cohort.

P2860

Q37693410-05A27514-BBF4-4A20-83D6-F3276CC1749A

P2860

High prevalence of BRCA1 stop mutation c.4183C>T in the Tyrolean population: implications for genetic testing

Item

http://www.wikidata.org/entity/Q36474986

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

High prevalence of BRCA1 stop ...... plications for genetic testing

@ast

High prevalence of BRCA1 stop ...... plications for genetic testing

@en

type

Item

label

High prevalence of BRCA1 stop ...... plications for genetic testing

@ast

High prevalence of BRCA1 stop ...... plications for genetic testing

@en

prefLabel

High prevalence of BRCA1 stop ...... plications for genetic testing

@ast

High prevalence of BRCA1 stop ...... plications for genetic testing

@en

P1476

High prevalence of BRCA1 stop ...... plications for genetic testing

@en

P2093

Albert Amberger

http://www.w3.org/2001/XMLSchema#string

Anne Oberguggenberger

http://www.w3.org/2001/XMLSchema#string

Annekatrin Wernstedt

http://www.w3.org/2001/XMLSchema#string

Christian Marth

http://www.w3.org/2001/XMLSchema#string

Christine Fauth

http://www.w3.org/2001/XMLSchema#string

Ingrid Weber

http://www.w3.org/2001/XMLSchema#string

Johannes Zschocke

http://www.w3.org/2001/XMLSchema#string

Katharina Wimmer

http://www.w3.org/2001/XMLSchema#string

Michael Hubalek

http://www.w3.org/2001/XMLSchema#string

Pia Traunfellner

http://www.w3.org/2001/XMLSchema#string

P2860

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer

Study of a single BRCA2 mutation with high carrier frequency in a small population

Integrated genomic analyses of ovarian carcinoma

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

Multiplex SNaPshot for detection of BRCA1/2 common mutations in Spanish and Spanish related breast/ovarian cancer families

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.

LOVD v.2.0: the next generation in gene variant databases.

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

P2888

ejhg.2015.108

P304

258-262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EJHG.2015.108

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Barbara Sperner-Unterweger

Heidi Fiegl

Laura Pölsler

P577

2015-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277412639

http://www.w3.org/2001/XMLSchema#string

P698

26014432

http://www.w3.org/2001/XMLSchema#string

P932

4717197

http://www.w3.org/2001/XMLSchema#string

High prevalence of BRCA1 stop mutation c.4183C>T in the Tyrolean population: implications for genetic testing

about

P2860

P2860

High prevalence of BRCA1 stop mutation c.4183C>T in the Tyrolean population: implications for genetic testing

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932